Distinct fibronectin splicing variants: potential targets for therapeutic immunomodulation in organ allograft recipients.
Coito
A J
AJ
Harvard Medical School, Dept of Surgery, Brigham & Women's Hospital, Boston, Massachusetts 02115, USA.
Korom
S
S
Van de Water
L
L
Kupiec-Weglinski
J W
JW
D017398:Alternative Splicing; D000818:Animals; D005353:Fibronectins / Q000096:biosynthesis* / Q000737:chemistry / Q000276:immunology; D014644:Genetic Variation; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D007165:Immunosuppression Therapy / Q000379:methods; D039041:Integrin alpha4beta1; D016023:Integrins / Q000037:antagonists & inhibitors / Q000502:physiology; D010446:Peptide Fragments / Q000494:pharmacology*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D016201:Receptors, Lymphocyte Homing / Q000037:antagonists & inhibitors / Q000502:physiology; D016029:Receptors, Very Late Antigen / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D013997:Time Factors; D014184:Transplantation, Homologous
D005353:Fibronectins; D039041:Integrin alpha4beta1; D016023:Integrins; D010446:Peptide Fragments; D016201:Receptors, Lymphocyte Homing; D016029:Receptors, Very Late Antigen